시장보고서
상품코드
1564084

세계의 전체 슬라이드 영상(WSI) 시장

Whole Slide Imaging

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 197 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전체 슬라이드 영상(WSI) 세계 시장은 2030년까지 29억 달러에 달할 것으로 예상됩니다

2023년 8억 9,070만 달러로 추정되는 세계 전체 슬라이드 영상(WSI) 시장은 2023년부터 2030년까지 연평균 18.3% 성장하여 2030년에는 29억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 전체 슬라이드 영상(WSI) 하드웨어는 CAGR 18.9%를 기록하여 분석 기간 종료 시점에 15억 달러에 도달할 것으로 예상됩니다. 전체 슬라이드 영상(WSI) 소프트웨어 분야의 성장률은 분석 기간 동안 CAGR 17.8%로 추정됩니다.

미국 시장은 2억 4,150만 달러로 추정, 중국은 CAGR 16.9%로 성장 전망

미국의 전체 슬라이드 영상(WSI) 시장은 2023년 2억 4,150만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 16.9%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 4억 2,460만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 16.5%와 15.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 13.0%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

전 세계 슬라이드 전체 이미징 시장 - 주요 동향 및 촉진요인 요약

전체 슬라이드 영상(WSI)이 병리 및 진단 업무를 변화시키는 이유는 무엇인가?

전체 슬라이드 영상(WSI)(WSI)은 전체 조직 슬라이드를 디지털화하여 병리 슬라이드의 고해상도 검사, 저장 및 공유를 가능하게 함으로써 병리학 및 진단 분야에 혁명을 일으키고 있습니다. 이 기술은 원격 진료, 디지털 아카이빙 및 AI 기반 분석을 용이하게 하여 종양학, 혈액학 및 감염성 질환의 진단 정확도와 효율성을 향상시킵니다. 진단 워크플로우 개선, 텔레파솔로지, 인공지능 통합의 필요성으로 인해 디지털 파솔로지의 채택이 증가하면서 WSI 시스템에 대한 수요가 증가하고 있습니다. 개인 맞춤형 의료의 부상과 정확하고 재현 가능한 진단 데이터의 필요성으로 인해 WSI는 현대 의료에서 매우 중요한 도구가 되고 있습니다.

기술의 발전은 전체 슬라이드 영상(WSI) 시스템을 어떻게 향상시키고 있는가?

이미징 하드웨어, 데이터 관리 및 인공지능의 기술 발전은 전체 슬라이드 영상(WSI) 시스템의 기능과 응용을 크게 향상시키고 있습니다. 더 높은 해상도와 초점 심도를 가진 고속 스캐너의 개발로 조직의 형태와 병리를 보다 정확하고 상세하게 시각화할 수 있게 되었습니다. 데이터 압축 및 클라우드 스토리지 솔루션의 혁신은 대규모 이미지 데이터 세트의 처리, 저장 및 검색을 개선하여 병리 검사실에서 원활한 디지털 워크플로우를 촉진하고 있습니다. 또한 AI와 머신러닝 알고리즘의 통합은 자동 이미지 분석, 패턴 인식 및 예측 진단을 가능하게 하여 병리학자의 업무 부담을 줄이고 진단 정확도를 향상시키고 있습니다. 이러한 발전은 임상 진단, 연구 및 교육 분야에서 WSI의 채택을 촉진하고 있습니다.

전체 슬라이딩 이미징 시장의 과제와 기회는?

전체 슬라이드 영상(WSI) 시장은 WSI 시스템의 높은 초기 비용, 데이터 관리의 복잡성, 디지털 병리 플랫폼 간의 표준화 및 상호 운용성의 필요성 등 여러 가지 과제에 직면해 있습니다. 또한, 규제 장벽과 디지털 병리 시스템의 임상적 사용에 대한 검증의 필요성이 디지털 병리 시스템의 채택을 지연시킬 수 있습니다. 그러나 이러한 도전은 성장과 혁신의 기회가 될 수도 있습니다. 고화질 이미지, 기존 검사 인프라와의 손쉬운 통합, 강력한 데이터 관리 기능을 제공하는 비용 효율적이고 확장 가능한 WSI 솔루션의 개발은 임상과 연구 분야 모두에서 채택을 촉진하는 데 도움이 될 수 있습니다. 세컨드 오피니언(second opinion)과 전문 지식에 대한 요구로 인해 텔레파솔로지 및 원격 진단에 대한 수요가 증가하고 있으며, 이는 원활한 디지털 진료와 협업을 지원하는 WSI 시스템에 대한 새로운 성장 기회를 창출하고 있습니다. 또한, AI 기반 진단 및 정밀의료에 대한 관심이 높아지면서 임상적 의사결정을 위한 신뢰할 수 있고 재현성 있는 데이터를 제공하는 고급 WSI 솔루션에 대한 필요성이 증가하고 있습니다.

전체 슬라이딩 이미징 시장의 성장 원동력은?

전체 슬라이딩 이미징 시장의 성장은 디지털 병리학의 채택 증가, 원격 병리 및 원격 진단에 대한 수요 증가, 이미징 하드웨어, 데이터 관리 및 AI 기반 분석의 기술 발전 등 여러 가지 요인에 의해 주도되고 있습니다. 병리 진단의 진단 정확도 향상, 효율성 및 협업의 필요성이 임상 및 연구 현장에서 WSI 시스템에 대한 시장 수요를 크게 증가시키고 있습니다. 고해상도 이미징, 클라우드 스토리지, AI 기반 분석의 기술 혁신은 WSI 시스템의 기능과 확장성을 향상시켜 병원, 연구기관, 진단 실험실에 더욱 매력적으로 다가오고 있습니다. 또한, 개인 맞춤형 의료의 확대와 디지털 헬스케어 혁신에 대한 관심이 높아지면서 이해관계자들이 진단 워크플로우와 환자 결과를 개선할 수 있는 첨단 디지털 병리 도구를 찾고 있는 것도 시장 성장의 원동력이 되고 있습니다.

조사 대상 기업 예시(주목받는 47개 기업)

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.10.04

Global Whole Slide Imaging Market to Reach US$2.9 Billion by 2030

The global market for Whole Slide Imaging estimated at US$890.7 Million in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Whole Slide Imaging Hardware, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Whole Slide Imaging Software segment is estimated at 17.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.5 Million While China is Forecast to Grow at 16.9% CAGR

The Whole Slide Imaging market in the U.S. is estimated at US$241.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$424.6 Million by the year 2030 trailing a CAGR of 16.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Whole Slide Imaging Market - Key Trends & Drivers Summarized

Why Is Whole Slide Imaging Transforming Pathology and Diagnostic Practices?

Whole Slide Imaging (WSI) is revolutionizing the field of pathology and diagnostic practices by enabling the digitization of entire histological slides, allowing for high-resolution examination, storage, and sharing of pathology slides. This technology facilitates remote consultations, digital archiving, and AI-driven analysis, enhancing the accuracy and efficiency of diagnostics in oncology, hematology, and infectious diseases. The increasing adoption of digital pathology, driven by the need for improved diagnostic workflows, telepathology, and the integration of artificial intelligence, is propelling the demand for WSI systems. With the rise of personalized medicine and the need for precise and reproducible diagnostic data, WSI is becoming a crucial tool in modern healthcare.

How Are Technological Advancements Enhancing Whole Slide Imaging Systems?

Technological advancements in imaging hardware, data management, and artificial intelligence are significantly enhancing the capabilities and applications of whole slide imaging systems. The development of high-speed scanners with higher resolution and depth of focus is enabling more accurate and detailed visualization of tissue morphology and pathology. Innovations in data compression and cloud storage solutions are improving the handling, storage, and retrieval of large image datasets, facilitating seamless digital workflows in pathology labs. Additionally, the integration of AI and machine learning algorithms is enabling automated image analysis, pattern recognition, and predictive diagnostics, reducing the workload on pathologists and increasing diagnostic accuracy. These advancements are driving the adoption of WSI in clinical diagnostics, research, and education.

What Are the Challenges and Opportunities in the Whole Slide Imaging Market?

The whole slide imaging market faces several challenges, including high initial costs of WSI systems, data management complexities, and the need for standardization and interoperability across digital pathology platforms. Additionally, regulatory hurdles and the need for validation of digital pathology systems for clinical use can slow down adoption. However, these challenges also present opportunities for growth and innovation. The development of cost-effective and scalable WSI solutions that offer high-quality imaging, easy integration with existing lab infrastructure, and robust data management capabilities can help drive adoption in both clinical and research settings. The increasing demand for telepathology and remote diagnostics, driven by the need for second opinions and specialized expertise, is creating new growth opportunities for WSI systems that support seamless digital consultation and collaboration. Moreover, the rising focus on AI-driven diagnostics and precision medicine is driving the need for advanced WSI solutions that provide reliable and reproducible data for clinical decision-making.

What Is Driving the Growth of the Whole Slide Imaging Market?

The growth in the Whole Slide Imaging market is driven by several factors, including the increasing adoption of digital pathology, rising demand for telepathology and remote diagnostics, and technological advancements in imaging hardware, data management, and AI-driven analysis. The need for improved diagnostic accuracy, efficiency, and collaboration in pathology is significantly boosting market demand for WSI systems in clinical and research settings. Technological innovations in high-resolution imaging, cloud storage, and AI-based analytics are enhancing the capabilities and scalability of WSI systems, making them more attractive to hospitals, research institutes, and diagnostic labs. The expansion of personalized medicine and the growing emphasis on digital healthcare transformation are also driving market growth as stakeholders seek advanced digital pathology tools to enhance diagnostic workflows and patient outcomes.

Select Competitors (Total 47 Featured) -

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Whole Slide Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Digital Pathology Solutions Drives Whole Slide Imaging Market
    • Technological Advancements in Imaging and Analysis Propel Market Growth
    • Increased Adoption in Clinical Diagnostics Enhances Whole Slide Imaging Utilization
    • Growth in Cancer Research Necessitates Efficient Whole Slide Imaging Solutions
    • Integration of AI and Machine Learning in Image Analysis Expands Capabilities
    • Global Expansion of Telepathology Services Amplifies Whole Slide Imaging Demand
    • Regulatory and Compliance Requirements Influence Whole Slide Imaging Adoption
    • Developments in High-Throughput Scanning Technologies Boost Market Efficiency
    • Rising Healthcare Expenditure Worldwide Sustains Investment in Digital Imaging
    • Technological Convergence in Healthcare IT Systems Promotes Interoperability
    • Data Management and Storage Challenges Drive Solutions in Digital Pathology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Slide Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Telepathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Telepathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cytopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Cytopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hematopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Hematopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • JAPAN
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CHINA
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • EUROPE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • FRANCE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • GERMANY
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • UNITED KINGDOM
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제